RYTM EPS Estimates
Rhythm Pharmaceuticals, Inc.
$112.28
+$7.26(+6.91%)
69
Overall
40
Value
90
Tech
78
Quality
Market Cap
$7.78B
Volume
4.94M
52W Range
$74.50 - $122.20
Target Price
$140.78
RYTM EPS estimates: the consensus estimate for Rhythm Pharmaceuticals, Inc.'s current fiscal year is -$3.57 per share. Quarterly and next-year EPS forecasts, growth estimates and revenue projections follow.
RYTM EPS Estimates
- EPS estimate, current quarter
- $-1.95
- EPS estimate, next quarter
- $-0.48
- EPS estimate, current year
- $-3.57
- EPS estimate, next year
- $-0.78
- EPS growth, 3-year
- +3.59%
| Fiscal year | EPS |
|---|---|
| 2025 | $-3.11 |
| 2024 | $-4.34 |
| 2023 | $-3.20 |
| 2022 | $-3.47 |
| 2021 | $-1.40 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | RYTM | $112.28 | +6.9% | 4.94M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Rhythm Pharmaceuticals, Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW